Co-colonization by multidrug-resistant bacteria in two Greek intensive care units
- PMID: 26173689
- DOI: 10.1007/s10096-015-2436-4
Co-colonization by multidrug-resistant bacteria in two Greek intensive care units
Abstract
Our goal was to identify the risk factors for co-colonization by KPC-producing Klebsiella pneumoniae (KPC-Kp), vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA) upon intensive care unit (ICU) admission and during stay. Rectal and nasal samples were taken from each patient upon admission at two Greek ICUs and each week afterwards, and were inoculated onto chromogenic agar. Representative colonies were characterized with standard methods and Vitek-2 technology. The presence of the bla KPC gene (K. pneumoniae isolates), vanA and vanB (Enterococcus faecium and E. faecalis isolates), and mecA (S. aureus isolates) was confirmed by polymerase chain reaction (PCR). Upon ICU admission, among 481 patients, 59 (12%), 63 (13%), and 20 (4%) were colonized by KPC-Kp, VRE, or MRSA, respectively. Simultaneous colonization by KPC-Kp and VRE upon admission (34 patients) was associated with the number of co-morbidities [adjusted odds ratio (aOR): 1.5; confidence interval (CI) 1.0-2.5], administered antibiotics (aOR: 1.7; CI 1.3-2.3), and prior KPC-Kp infection (aOR: 24.4; CI 1.5-396.0). Among patients with an ICU stay of more than 6 days, 181 (73%), 31 (13%), and 9 (4%) became KPC-Kp, VRE, or MRSA colonized during ICU stay, respectively. KPC-Kp colonization was an independent risk factor for VRE colonization upon admission (aOR: 2.7; CI 1.0-7.2) and during stay (aOR: 7.4; CI 2.0-27.4), whereas VRE colonization was a risk factor for KPC-Kp upon admission (aOR: 5.1; CI 1.9-13.9) and MRSA colonization upon admission (aOR: 3.5; CI 1.2-10.1) and during ICU stay (aOR: 14.5; CI 2.1-100.1). Colonization by a multidrug pathogen could promote colonization by another.
Similar articles
-
Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis.J Hosp Infect. 2009 Nov;73(3):239-45. doi: 10.1016/j.jhin.2009.07.017. Epub 2009 Oct 4. J Hosp Infect. 2009. PMID: 19804919
-
Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission.J Antimicrob Chemother. 2012 Dec;67(12):2976-81. doi: 10.1093/jac/dks316. Epub 2012 Aug 26. J Antimicrob Chemother. 2012. PMID: 22927316
-
KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.Diagn Microbiol Infect Dis. 2013 Oct;77(2):169-73. doi: 10.1016/j.diagmicrobio.2013.06.007. Epub 2013 Jul 23. Diagn Microbiol Infect Dis. 2013. PMID: 23886789
-
Management of KPC-producing Klebsiella pneumoniae infections.Clin Microbiol Infect. 2018 Feb;24(2):133-144. doi: 10.1016/j.cmi.2017.08.030. Epub 2017 Sep 9. Clin Microbiol Infect. 2018. PMID: 28893689 Review.
-
Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.J Antimicrob Chemother. 2021 Jan 29;76(Suppl 1):i19-i26. doi: 10.1093/jac/dkaa494. J Antimicrob Chemother. 2021. PMID: 33534878 Review.
Cited by
-
A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis.Crit Care. 2025 Jan 13;29(1):21. doi: 10.1186/s13054-024-05232-3. Crit Care. 2025. PMID: 39806400 Free PMC article. Clinical Trial.
-
Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study.Microorganisms. 2023 Dec 12;11(12):2970. doi: 10.3390/microorganisms11122970. Microorganisms. 2023. PMID: 38138114 Free PMC article.
-
Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis.Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):127-134. doi: 10.1007/s10096-017-3110-9. Epub 2017 Sep 30. Eur J Clin Microbiol Infect Dis. 2018. PMID: 28963603
-
The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission.Antimicrob Resist Infect Control. 2023 Oct 28;12(1):118. doi: 10.1186/s13756-023-01326-9. Antimicrob Resist Infect Control. 2023. PMID: 37898771 Free PMC article.
-
Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015-2019).BMC Infect Dis. 2021 Nov 27;21(1):1196. doi: 10.1186/s12879-021-06900-3. BMC Infect Dis. 2021. PMID: 34837973 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical